发明名称 Novobiocin analogues having modified sugar moieties
摘要 The disclosure provides novobiocin analogues with noviose replacements which are useful as Hsp90 inhibitors in the treatment of cancer.
申请公布号 US9120774(B2) 申请公布日期 2015.09.01
申请号 US201013202382 申请日期 2010.02.19
申请人 University of Kansas 发明人 Blagg Brian S. J.;Zhao Huiping;Donnelly Alison Catherine
分类号 C07H17/06;C07D407/12;C07D487/14;C07H19/00 主分类号 C07H17/06
代理机构 Parker Highlander PLLC 代理人 Parker Highlander PLLC
主权项 1. A compound according to Formula I; or a pharmaceutically acceptable salt thereof: wherein: R1 is —NHCOR″, where R″ is: an aryl substituted with one or more hydroxy, nitro, amino, alkyl, alkenyl, aryl, alkoxy or halo groups;a heterocyclic group, wherein the heterocyclic group is aromatic, wherein the heterocyclic group is optionally substituted with one or more hydroxy, nitro, amino, alkyl, alkenyl, aryl, alkoxy or halo groups; or wherein R24 and R25 are each independently H, C1-C4 alkyl, hydroxy or alkoxy; and R33 is H, C1-C4 alkyl, C1-C4 alkylamino, —(CO)—C1-C4 alkyl, or piperidinyl, each optionally substituted with C1-C4 alkyl; and R31 is H, halo, C1-C4 alkyl, hydroxy or alkoxy; and R32 is H or C1-C4 alkyl; X9 is: —O-alkyl, substituted with one or more amino, amido, alkyl, alkoxy, halo, pyrrolidinyl, or hydroxyl groups;—O—alkylamino, —O—cycloalkyl, —O—(CO)—alkyl, —O—(CO)—cycloalkyl, —O—(CH2)n—pyridinyl, —O—(CH2)n-piperidinyl, —O—(CH2)n—pyrrolino, or —O—(CH2)n—pyrrolidinyl, each optionally substituted with one or more amino, amido alkyl, halo, alkoxy, or hydroxyl groups; and where n is 0, 1, 2 or 3;—O—mono-hydroxylated furanose, —O—dihydroxylated furanose, —O—mono-hydroxylated pyranose, —O—dihydroxylated pyranose, —O—trihydroxylated pyranose, —O—mono-hydroxylatedoxepinose, —O—dihydroxylated oxepinose, —O-azasugar, —O—acyl; orester, amino, amido, carbamate, phosphate ester, tosylate or mesylate; X is H, nitrile, halo, amino, amido, C1-C4 alkyl or alkoxy; and Y is H, amido, ester, amino, C1-C4 alkyl or alkoxy.
地址 Lawrence KS US